Moteur de recherche d’entreprises européennes
Financement de l’UE (999 475 €) : SMART : Formation avancée à la recherche sur les petits médicaments Hor01/01/2016 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
SMART : Formation avancée à la recherche sur les petits médicaments
SMART Project is aimed to raise IPCZD staff’s research profile and increase capacity in providing innovative paediatric research methods such as PK-PD data Modelling&Simulation (M&S) data extrapolation, and suitable dosage forms identification. This represents both a specific IPCZD’s need (PCZD has a solid experience in providing and accumulating paediatric PK-PD data but is unable to use this data in the contest of innovative study’ methodologies) and a globally recognised research need (paediatric clinical research is affected by many methodological ethical and logistic hurdles requiring new methods will be generated and developed through a large and experienced scientific communities involving different expertise and having a composite background. Methods such as M&S and extrapolation aimed to optimise evidence synthesis, while minimising evidence generation represent at today the more promising frontier of the paediatric research). To improve the level of high-quality paediatric research in Poland, it is proposed a composite training programme addressing staff from PCZD including lessons (e-learning and face to face), staff exchanges and summer schools. Three internationally-leading research institutions, CVBF in Italy, UCL in the United Kingdom and AMU in France will contribute to the training program by providing specific expertise in paediatric clinical trial government and developing, M&S and Extrapolation applications, new formulation generation. All these institution have a solid experience and previous participation in large paediatric research Networks and Consortia. PCZD is a large tertiary paediatric hospital, having a strong interest in paediatric research. As PCZD staff will enhance its know-how on paediatric trials and drug development, the institution is expected to be candidate to assume a leading role in the paediatric research European framework, also became attractive for private-public collaborations.
| Consorzio Per Valutazioni Biologiche E Farmacologiche | 389 807 € |
| Instytut Pomnik Centrum Zdrowia Dziecka | 392 025 € |
| Universite d'AIX Marseille | 19 768,04 € |
| University College London | 197 875 € |
https://cordis.europa.eu/project/id/692327
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
